| The effect of taurine supplementation on delirium post liver transplantation: A randomized controlled trial 2022 · taurine group · Adults older than 18 years who had received a liver transplant | 2 g | 30 days | — |
| The effect of acute taurine ingestion on 3-km running performance in trained middle-distance runners 2013 · TA trial · Male trained middle-distance runners; mean age 19.9 years | 1 g | 1 day | 8 |
| Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial 2015 · Taurine · Adults aged 75 years or older with a primary hip fracture scheduled for surgery | 3.6 g | 6 days | 113 |
| Normalization of heart rate variability with taurine and meldonium complex in post-infarction patients with type 2 diabetes mellitus 2019 · 1st subgroup (taurine) · Adults with post-infarction cardiosclerosis and type 2 diabetes; median age approximately 65 years; women and men | 1.2 g | 12 weeks | 22 |
| Taurine attenuates chemotherapy-induced nausea and vomiting in acute lymphoblastic leukemia 2015 · taurine · Patients aged 16–23 with acute lymphoblastic leukemia receiving maintenance chemotherapy | 2 g | 26 weeks | 20 |
| The effects of taurine ingestion on anaerobic and physiological performance in female rugby players 2024 · LOWTAU · Sub-elite female rugby athletes, mean age 21.3 years | 2 g | 1 day | 16 |
| Effect of taurine supplementation on exercise capacity of patients with heart failure 2011 · taurine supplementation · Adults with heart failure, LVEF below 50%, NYHA functional class II or III; mean age 60.57 years, mostly male | 1.5 g | 2 weeks | 15 |
| The effect of acute taurine ingestion on endurance performance and metabolism in well-trained cyclists 2010 · taurine trial · Endurance-trained men, mean age 27.2 years | 1.66 g | 1 day | 11 |
| Exercise and taurine in inflammation, cognition, and peripheral markers of blood-brain barrier integrity in older women 2018 · exercise training associated with taurine (CET+TAU) · Elderly women (mean age 83.58 ± 6.9 years) | 1.5 g | 14 weeks | 11 |
| Taurine Supplementation Improves Functional Capacity, Myocardial Oxygen Consumption, and Electrical Activity in Heart Failure 2017 · taurine (TG) · Patients with heart failure; age and sex not stated | 1.5 g | 2 weeks | 8 |
| Randomised clinical trial: oral taurine supplementation versus placebo reduces muscle cramps in patients with chronic liver disease 2018 · Taurine supplementation · Patients with chronic liver disease who experienced three or more muscle cramps per week; mean age 54.7 years, 70% male | 2 g | 4 weeks | — |
| Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study 2016 · taurine · Patients aged 18–25 with first-episode psychotic disorder taking low-dose antipsychotic medication | 4 g | 12 weeks | 47 |
| Normalization of heart rate variability with taurine and meldonium complex in post-infarction patients with type 2 diabetes mellitus 2019 · 3rd subgroup (combined meldonium and taurine) · Adults with post-infarction cardiosclerosis and type 2 diabetes; median age approximately 65 years; women and men | 1.2 g | 12 weeks | 23 |
| Does Single or Combined Caffeine and Taurine Supplementation Improve Athletic and Cognitive Performance without Affecting Fatigue Level in Elite Boxers? A Double-Blind, Placebo-Controlled Study 2022 · taurine (TAU) · Elite male boxers; mean age 22.14 ± 1.42 years | 3 g | 1 day | 20 |
| The effects of taurine ingestion on anaerobic and physiological performance in female rugby players 2024 · MODTAU · Sub-elite female rugby athletes, mean age 21.3 years | 4 g | 1 day | 16 |
| The effects of taurine ingestion on anaerobic and physiological performance in female rugby players 2024 · HIGHTAU · Sub-elite female rugby athletes, mean age 21.3 years | 6 g | 1 day | 16 |
| The effect of 8-day oral taurine supplementation on thermoregulation during low-intensity exercise at fixed heat production in hot conditions of incremental humidity 2024 · taurine condition · Healthy, non-heat-acclimated adults; 3 females and 12 males, mean age 27 ± 5 years | 50 mg/kg | 8 days | 15 |
| Effects of taurine supplementation on VDT work induced visual stress 2004 · taurine supplementation · Male college students aged 20–24 years, not engaged in VDT work | 3 g | 12 days | 13 |
| Acute taurine supplementation enhances thermoregulation and endurance cycling performance in the heat 2019 · Taurine · 11 healthy males | 50 mg/kg | 1 day | 11 |
| Additional effects of taurine on the benefits of BCAA intake for the delayed-onset muscle soreness and muscle damage induced by high-intensity eccentric exercise 2013 · TAU alone · Untrained male volunteers | 6 g | 18 days | 9 |
| The Effects of Caffeine, Taurine, or Caffeine-Taurine Coingestion on Repeat-Sprint Cycling Performance and Physiological Responses 2017 · T (taurine) · Seven male team-sport players | 50 mg/kg | 1 day | 7 |
| Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study 2016 · taurine supplementation · Prehypertensive individuals; age and sex not specified | 1.6 g | 12 weeks | — |
| Acute effects of energy drink consumption on microvascular reactivity in young male volunteers at rest: a randomized trial 2024 · Energy drink · Healthy men aged 18–35 years | 100 mg | 1 day | 32 |
| Does Single or Combined Caffeine and Taurine Supplementation Improve Athletic and Cognitive Performance without Affecting Fatigue Level in Elite Boxers? A Double-Blind, Placebo-Controlled Study 2022 · caffeine and taurine (CAF*TAU) · Elite male boxers; mean age 22.14 ± 1.42 years | 3 g | 1 day | 20 |
| Additional effects of taurine on the benefits of BCAA intake for the delayed-onset muscle soreness and muscle damage induced by high-intensity eccentric exercise 2013 · TAU and BCAA · Untrained male volunteers | 6 g | 18 days | 9 |
| The Effects of Caffeine, Taurine, or Caffeine-Taurine Coingestion on Repeat-Sprint Cycling Performance and Physiological Responses 2017 · C + T (caffeine and taurine) · Seven male team-sport players | 50 mg/kg | 1 day | 7 |
| Preexercise energy drink consumption does not improve endurance cycling performance but increases lactate, monocyte, and interleukin-6 response 2014 · energy drink (ED) · Trained male cyclists; mean age 33.4 years; condition not stated | 2 g | 1 day | — |
| Efficacy and Safety of "URSA Complex" in Subjects with Physical Fatigue: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial 2016 · URSA Complex · Adults older than 19 with persistent or chronic fatigue for at least 1 month and a baseline CIS score of at least 76; both sexes | 600 mg | 4 weeks | 81 |
| TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD 2007 · Sham MCS and nutritional supplement · Adults aged 50–90 with dry age-related macular degeneration in at least one eye | 400 mg | 24 weeks | 37 |
| Improved cycling time-trial performance after ingestion of a caffeine energy drink 2009 · Red Bull Energy Drink · Trained male and female cyclists; mean age 27.3 years | 2 g | 1 day | 12 |
| Effects of creatine supplementation on body composition, strength, and sprint performance 1998 · Phosphagen HP (HP) · NCAA Division IA football players undergoing resistance/agility training; age and sex not stated | 3 g | 4 weeks | — |
| Cardio- and cerebrovascular responses to the energy drink Red Bull in young adults: a randomized cross-over study 2014 · Red Bull · Healthy adults aged 20–31 years, women and men, without reported cardiovascular disease or medication affecting cardiovascular or autonomic regulation | 1.42 g | 1 day | 25 |
| Comparison of the effects of energy drink versus caffeine supplementation on indices of 24-hour ambulatory blood pressure 2012 · Energy drink · Healthy, nonsmoking, normotensive volunteers aged 18–45 years | 4 g | 1 day | 9 |
| Taurine as a possible antiaging therapy: A controlled clinical trial on taurine antioxidant activity in women ages 55 to 70 2022 · taurine group (GTAU) · Women aged 55 to 70 years | 1.5 g | 16 weeks | 13 |
| Exercise and taurine in inflammation, cognition, and peripheral markers of blood-brain barrier integrity in older women 2018 · taurine supplementation (TAU) · Elderly women (mean age 83.58 ± 6.9 years) | 1.5 g | 14 weeks | 12 |
| Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis 1990 · taurine · Patients with chronic hepatitis; age and sex not reported | 1.5 g | 60 days | — |
| Taurine supplementation has anti-atherogenic and anti-inflammatory effects before and after incremental exercise in heart failure 2017 · taurine supplementation · Patients with heart failure, left ventricular ejection fraction less than 50%, NYHA functional class II or III | 1.5 g | 2 weeks | — |
| Oxidative stress and inflammation in obesity after taurine supplementation: a double-blind, placebo-controlled study 2014 · taurine group · Women with obesity diagnosis | 3 g | 8 weeks | 8 |
| Taurine supplementation in conjunction with exercise modulated cytokines and improved subcutaneous white adipose tissue plasticity in obese women 2021 · Taurine supplementation group (Tau) · Obese women | 3 g | 8 weeks | 8 |
| Taurine supplementation in conjunction with exercise modulated cytokines and improved subcutaneous white adipose tissue plasticity in obese women 2021 · Taurine supplementation + exercise group (Tau + Exe) · Obese women | 3 g | 8 weeks | 8 |
| Effects of Dietary Taurine Supplementation on Blood and Urine Taurine Concentrations in the Elderly Women with Dementia 2019 · dietary taurine supplemented group · elderly women with dementia | 3 g | 4 weeks | — |
| The effects of taurine supplementation on glycemic control and serum lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial 2020 · taurine group · Patients with type 2 diabetes | 3 g | 8 weeks | 23 |
| Comparative Study to Evaluate the Effect of Low-Protein Diet Supplementation with Taurine and N-Acetylcysteine, N-Acetylcysteine and Pyridoxamine Dihydrochloride in Preventing the Progression of Chronic Renal Failure in Patients with Non-Diabetic Kidney Disease 2022 · NT (taurine + NAC) arm · Adults with non-diabetic chronic renal failure, GFR >15 and <60 ml/min/1.73 m², receiving standard care | 1 g | 26 weeks | 23 |
| Effect of weight-loss diet combined with taurine supplementation on body composition and some biochemical markers in obese women: a randomized clinical trial 2020 · intervention (standard weight-loss group + cap Tau 3 g/day) · Obese women; age range not reported | 3 g | 8 weeks | 20 |
| Taurine Supplementation Increases Post-Exercise Lipid Oxidation at Moderate Intensity in Fasted Healthy Males 2020 · TAU 3 g · Healthy, physically active men; mean age 24.8 years; no stated condition | 3 g | 1 day | 17 |
| Taurine Supplementation Increases Post-Exercise Lipid Oxidation at Moderate Intensity in Fasted Healthy Males 2020 · TAU 6 g · Healthy, physically active men; mean age 24.8 years; no stated condition | 6 g | 1 day | 17 |
| Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects 2004 · taurine group · Overweight or obese non-diabetic college students, mean age 20.3 years | 3 g | 7 weeks | 15 |
| Effects of Taurine Supplementation on Vascular Endothelial Function at Rest and After Resistance Exercise 2019 · taurine supplement group · healthy men | 6 g | 17 days | 15 |
| Taurine decreases fecal fatty acid and sterol excretion in cystic fibrosis. A randomized double-blind trial 1991 · taurine · children with cystic fibrosis and significant steatorrhea (>13 g/d) | 30 mg/kg | 120 days | 13 |
| Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension 2018 · taurine group · Adults with cirrhosis and varices, hepatic venous pressure gradient (HVPG) ≥12 mm Hg | 6 g | 4 weeks | 12 |
| Effects of oral taurine supplementation on lipids and sympathetic nerve tone 1996 · T-group · Healthy men aged 18–29 years on an experimental high-fat, high-cholesterol diet | 6 g | 3 weeks | 11 |
| Taurine supplementation associated with exercise increases mitochondrial activity and fatty acid oxidation gene expression in the subcutaneous white adipose tissue of obese women 2021 · Taurine supplementation group (Tau) · Obese women, mean age 32.9 years, with mean BMI 33.1 kg/m² | 3 g | 8 weeks | 8 |
| Taurine supplementation associated with exercise increases mitochondrial activity and fatty acid oxidation gene expression in the subcutaneous white adipose tissue of obese women 2021 · Taurine supplementation + exercise group (TauEx) · Obese women, mean age 32.9 years, with mean BMI 33.1 kg/m² | 3 g | 8 weeks | 8 |
| Effect of cysteine derivatives administration in healthy men exposed to intense resistance exercise by evaluation of pro-antioxidant ratio 2007 · Taurine (TAU) · Healthy men exposed to intense resistance exercise | 3 g | 3 days | — |
| Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis 1990 · ursodeoxycholic acid plus taurine · Patients with chronic hepatitis; age and sex not reported | 1.5 g | 60 days | — |
| Effects of sulphur-containing compounds on plasma redox status in muscle-damaging exercise 2009 · Taurine (TAU) · Healthy, trained men | 3 g | 3 days | — |
| The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial 2021 · taurine group · Adults with type 2 diabetes | 3 g | 8 weeks | — |
| Possible ameliorative effect of taurine in the treatment of iron-deficiency anaemia in female university students of Gaza, Palestine 2002 · taurine group · Female university students with iron-deficiency anaemia | 1 g | 20 weeks | — |
| A multi-nutrient supplement reduced markers of inflammation and improved physical performance in active individuals of middle to older age: a randomized, double-blind, placebo-controlled study 2011 · BioCharge multi-nutrient supplement · Healthy, recreationally active men and women aged 40–70 years | 500 mg | 4 weeks | 31 |